Market Overview

Last Week's Biotech IPO Recap

Share:
Related ZSAN
28 Stocks Moving In Monday's Pre-Market Session
41 Biggest Movers From Thursday
Related ASND
5 Biggest Price Target Changes For Tuesday
20 Biggest Mid-Day Losers For Wednesday

Last week, eight biotech companies went public. Some of these companies traded much higher, while others traded lower.

Below is a recap of the IPOs from the week, and a look at how each performed on its first day of trading.

Zosano Pharma Corp (NASDAQ: ZSAN) offered 4.5 million shares on January 27 at $11. After the first day of trading, the stock closed at $11.01.

Ascendis Pharma A/S (NASDAQ: ASND) offered 6 million shares on January 28 at $18. After the first day of trading, the stock closed at $18.83.

Presbia PLC (NASDAQ: LENS) offered 4.2 million shares on January 29 at $10. After the first day of trading, the stock closed at $8.15.

Flex Pharma Inc (NASDAQ: FLKS) offered 5.4 million shares on January 29 at $16. After the first day of trading, the stock closed at $14.95.

Entellus Medical Inc (NASDAQ: ENTL) offered 4.6 million shares on January 29 at $17. After the first day of trading, the stock closed at $22.

TRACON Pharmaceuticals Inc (NASDAQ: TCON) offered 3.6 million shares on January 30 at $10. After the first day of trading, the stock closed at $9.40.

Spark Therapeutics Inc (NASDAQ: ONCE) offered 7 million shares on January 30 at $23. After the first day of trading, the stock closed at $50.

Avinger Inc (NASDAQ: AVGR) offered 5 million shares on January 30 at $14. After the first day of trading, the stock closed at $13.50.

Posted-In: Long Ideas Short Ideas FDA IPOs Trading Ideas

 

Related Articles (ASND + AVGR)

View Comments and Join the Discussion!